Menopausal women on hormone therapy (HT) should not stop their treatment prior to their annual mammogram screenings, researchers have indicated.
Annual mammography screening significantly reduces the breast cancer mortality in women older than 50, and is considered a pillar of routine healthcare maintenance.
Hormone Replacement Therapy
Hormone Replacement Therapy can be likened to an 'oasis in the desert' for women in the throes of menopause.
Advertisement
While subjective and objective increases in mammographic breast density have been reported in up to 30 percent of postmenopausal women taking HT, the majority of women in this age group have low breast densities to start with and the magnitude of the increase with HT is small in most.
Moreover, improvements in screening technologies (digital mammography) have shown promise in overcoming hindrances in denser breasts.
It is thus extremely unlikely that a minor increase in density is going to mask the mammographic detection of any early breast cancer if present.
![Birth Control Pills]( "Birth Control Pills")
Oral contraceptive or birth control pills contain hormones that prevent pregnancy. It is one of the most reliable methods of contraception.
"We do not believe everyone on HT should consider stopping treatment one to two months prior to their mammogram," said lead author Dr Raja Sayegh, an associate professor of obstetrics and gynecology at BUSM.
"Such a practice is likely to precipitate the recurrence of nuisance symptoms for which most menopausal women take HT nowadays, with no convincing evidence of improved screening accuracy.
"While there may be other good reasons to consider stopping HT, improving the mammographic detection of early cancers should not be one of them," he added.
While writing in Journal of the North American Menopause Society, the researchers recommend that health care providers should alert their HT patients to the possibility of an augmented mammographic density, or other artifacts, that may require additional evaluation.
Source: ANI
RAS
It is thus extremely unlikely that a minor increase in density is going to mask the mammographic detection of any early breast cancer if present.
Birth Control Pills
Oral contraceptive or birth control pills contain hormones that prevent pregnancy. It is one of the most reliable methods of contraception.
Advertisement
"We do not believe everyone on HT should consider stopping treatment one to two months prior to their mammogram," said lead author Dr Raja Sayegh, an associate professor of obstetrics and gynecology at BUSM.
"Such a practice is likely to precipitate the recurrence of nuisance symptoms for which most menopausal women take HT nowadays, with no convincing evidence of improved screening accuracy.
"While there may be other good reasons to consider stopping HT, improving the mammographic detection of early cancers should not be one of them," he added.
While writing in Journal of the North American Menopause Society, the researchers recommend that health care providers should alert their HT patients to the possibility of an augmented mammographic density, or other artifacts, that may require additional evaluation.
Source: ANI
RAS
Osteoporosis
Osteoporosis is a bone disease that leads to an increased risk of fractures. The bone mass is reduced and the bones are porous, thereby resulting in weakness of the skeletal system of the body.
Advertisement
 Breast Lumps-ScreeningBreast lumps must never be neglected but instead be subjected to medical examination to rule out cancer. | Advertisement
|
Advertisement
Recommended Readings
Latest Women Health News
More than a third of women worldwide encounter persistent health concerns, such as depression, lower back pain, and various childbirth-related conditions.
New findings lead to advancements in treating vaginal yeast infections by offering fresh insights into how microbes within the body absorb zinc.
An AI tool called Flan-T5 identified postpartum hemorrhage with 95% precision and detected 47% patients with the condition.
Active surveillance of cervical lesions was associated with higher cervical cancer risk in the long term compared to its removal.
Japan initiated the trial of selling morning-after contraceptive tablets over-the-counter in an effort to lower abortion rates and solace for rape victims.